Evidence map›Paper›PMID 28871172›Full record

ArticleNature communications2017

The cytoplasmic nuclear receptor RARγ controls RIP1 initiated cell death when cIAP activity is inhibited.

Qing Xu, Siriporn Jitkaew, Swati Choksi, Chamila Kadigamuwa, Jianhui Qu, Moran Choe, Jonathan Jang, Chengyu Liu, Zheng-Gang Liu

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. HNEAP Regulates Necroptosis of Cardiomyocytes by Suppressing the mAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  5. Article
  6. Targeting the Retinoic Acid Pathway to Eradicate Cancer Stem Cells.International journal of molecular sciences · 2023
    Review
  7. Article
  8. Article
  9. Antagonizing RARγ Drives Necroptosis of Cancer Stem Cells.International journal of molecular sciences · 2022
    Review
  10. Article
  11. Lessons to cancer from studies of leukemia and hematopoiesis.Frontiers in cell and developmental biology · 2022
    Review
  12. Retinoic Acid Receptor Gamma (RARMediators of inflammation · 2022
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. The RARγ Oncogene: An Achilles Heel for Some Cancers.International journal of molecular sciences · 2021
    Review
  18. Transition from TNF-Induced Inflammation to Death Signaling.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Qing XuCenter for Cancer Research, National Cancer Institute, 37 Convent Drive, Bethesda, MD, 20892, USA.
Siriporn JitkaewCenter for Cancer Research, National Cancer Institute, 37 Convent Drive, Bethesda, MD, 20892, USA.
Swati ChoksiCenter for Cancer Research, National Cancer Institute, 37 Convent Drive, Bethesda, MD, 20892, USA.
Chamila KadigamuwaCenter for Cancer Research, National Cancer Institute, 37 Convent Drive, Bethesda, MD, 20892, USA.
Jianhui QuCenter for Cancer Research, National Cancer Institute, 37 Convent Drive, Bethesda, MD, 20892, USA.
Moran ChoeCenter for Cancer Research, National Cancer Institute, 37 Convent Drive, Bethesda, MD, 20892, USA.
Jonathan JangCenter for Cancer Research, National Cancer Institute, 37 Convent Drive, Bethesda, MD, 20892, USA.
Chengyu LiuNational Heart Lung and Blood Institute, National Institutes of Health, 37 Convent Drive, Bethesda, MD, 20892, USA.
Zheng-Gang LiuCenter for Cancer Research, National Cancer Institute, 37 Convent Drive, Bethesda, MD, 20892, USA. zgliu@helix.nih.gov.
Center for Cancer Research · USNational Cancer Institute · USNational Institutes of Health · US

Funding

Transgenic CoreZICHL005907 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI LIU, CHENGYU · 2010 to 2025
$25.8M
CCR NIH HHS
6 · The paper itself

Abstract

Tumor necrosis factor (TNF) has a critical role in diverse cellular events including inflammation, apoptosis and necroptosis through different signaling complexes. However, little is known about how the transition from inflammatory signaling to the engagement of death pathways is modulated. Here we report that the cytoplasmic retinoic acid receptor gamma (RARγ) controls receptor-interacting protein kinase 1 (RIP1)-initiated cell death when cellular inhibitor of apoptosis (cIAP) activity is blocked. Through screening a short hairpin RNA library, we found that RARγ was essential for TNF-induced RIP1-initiated apoptosis and necroptosis. Our data suggests that RARγ initiates the formation of death signaling complexes by mediating RIP1 dissociation from TNF receptor 1. We demonstrate that RARγ is released from the nucleus to orchestrate the formation of the cytosolic death complexes. In addition, we demonstrate that RARγ has a similar role in TNF-induced necroptosis in vivo. Thus, our study suggests that nuclear receptor RARγ provides a key checkpoint for the transition from life to death.The molecular switch between how tumour necrosis factor (TNF) controls inflammation versus cell death is less well defined. Here, the authors show that the nuclear receptor retinoic acid receptor gamma is released from the nucleus to disrupt TNF initiated cell death complexes in the cytoplasm.

Indexed as

AnimalsApoptosisCell LineCell NucleusCytoprotectionCytosolInhibitor of Apoptosis ProteinsMice, KnockoutModels, BiologicalNuclear Pore Complex ProteinsReceptors, Retinoic AcidReceptors, Tumor Necrosis FactorRetinoic Acid Receptor gammaRNA-Binding ProteinsTNF Receptor-Associated Death Domain ProteinTumor Necrosis Factor-alphaAGFG1 protein, humanInhibitor of Apoptosis ProteinsNuclear Pore Complex ProteinsReceptors, Retinoic AcidReceptors, Tumor Necrosis FactorRetinoic Acid Receptor gammaRNA-Binding ProteinsTNF Receptor-Associated Death Domain ProteinTumor Necrosis Factor-alpha

Identifiers

PMID28871172
PMCPMC5583178
OpenAlexW2751989825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.